Skip to content
healthcare.dev
Get a free key

OGIVRI

NDC 83257-003, trastuzumab-dkst, injection, powder, lyophilized, for solution, from Biocon Biologics Inc..

Product NDC
83257-003
Status
Listed
Labeler
Biocon Biologics Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761074
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83257-003 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRASTUZUMAB420 mg/20mL

Pharmacologic classes

HER2/Neu/cerbB2 Antagonists [MoA]; HER2/neu Receptor Antagonist [EPC]

Package NDCNDC-11Package

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b6465b44-a6dd-f99c-d009-6851cf05169c

Use it

Look up 83257-003 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83257-003 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83257-003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.